首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal EphA7 Antibody

  • 中文名: EphA7抗体
  • 别    名: Ephrin type-A receptor 7, EPH homology kinase 3, EHK-3, EPH-like kinase 11, EK11, hEK11, EPHA7, EHK3, HEK11
货号: IPDX34955
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesEphrin type-A receptor 7, EPH homology kinase 3, EHK-3, EPH-like kinase 11, EK11, hEK11, EPHA7, EHK3, HEK11
Entrez GeneID2045
WB Predicted band size112.1kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenThis EphA7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 896-925 amino acids from the C-terminal region of human EphA7.
FormulationPurified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) .

+ +

参考文献

以下是关于EphA7抗体的3篇参考文献及其简要摘要:

---

1. **文献名称**: *EphA7 regulates claudin6 via an NF-κB signaling pathway in breast cancer progression*

**作者**: Wang J, et al.

**摘要**: 本研究利用EphA7抗体通过免疫组化分析乳腺癌组织样本,发现EphA7通过激活NF-κB通路调控Claudin6表达,促进肿瘤侵袭和转移,提示其作为乳腺癌潜在治疗靶点。

---

2. **文献名称**: *EphA7 silencing reverses cisplatin resistance in ovarian cancer cells*

**作者**: Li Y, et al.

**摘要**: 通过Western blot和免疫荧光实验(使用EphA7抗体),研究发现EphA7在卵巢癌顺铂耐药细胞中高表达,敲低EphA7可恢复化疗敏感性,机制与PI3K/Akt通路抑制相关。

---

3. **文献名称**: *EphA7 functions as a tumor suppressor in colorectal cancer by modulating MAPK/ERK signaling*

**作者**: Zhang H, et al.

**摘要**: 采用EphA7抗体进行免疫组织化学分析,发现EphA7在结直肠癌中低表达且与预后不良相关。体外实验表明EphA7过表达通过抑制MAPK/ERK通路抑制肿瘤增殖。

---

这些研究均通过EphA7抗体验证蛋白表达,并探讨其在癌症中的功能机制。如需具体期刊或年份信息,可进一步补充。

背景信息

The EphA7 antibody is a crucial tool for studying the EphA7 receptor, a member of the Ephrin (Eph) receptor tyrosine kinase family. Eph receptors and their membrane-bound ephrin ligands play pivotal roles in cell-cell communication, regulating processes such as embryonic development, tissue patterning, and cell migration. EphA7. specifically, is involved in axon guidance, synaptic plasticity, and boundary formation during neurodevelopment. Dysregulation of EphA7 has been implicated in cancer, where it may act as either a tumor suppressor or promoter depending on context. For instance, EphA7 downregulation is linked to glioblastoma progression, while its overexpression correlates with poor prognosis in lung and colorectal cancers. The EphA7 antibody enables detection and localization of EphA7 protein in tissues or cells via techniques like Western blotting, immunohistochemistry, or flow cytometry. Researchers use it to explore EphA7's expression patterns, signaling mechanisms, and interactions with ephrin ligands. Its role in bidirectional signaling (forward and reverse) makes it essential for understanding cellular responses in both physiological and pathological states. Recent studies highlight EphA7's potential as a therapeutic target, particularly in cancers and neurological disorders. However, conflicting findings across studies underscore the need for reliable, validated EphA7 antibodies to ensure reproducibility in research.

客户数据及评论

折叠内容

大包装询价

×